<DOC>
	<DOC>NCT01388530</DOC>
	<brief_summary>This proposal seeks to obtain preliminary data on the potential efficacy, tolerability, and feasibility of trigeminal nerve stimulation (TNS) as a treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). If successful, this open-label, exploratory, pilot study will provide a basis for a federal grant application and larger controlled trials.</brief_summary>
	<brief_title>Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>male and female youth age 9 to 14 years with Diagnostic and Statistical Manuel IV (DSMIV) ADHD, combined subtype as determined by Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS) and clinical interview minimum scores of 12 on both the inattentive and hyperactive/impulsive subscales of the baseline ADHDRating Scale (ADHDRS)S Clinical Global Impression Severity (CGIS) score at baseline no current medications with central nervous system (CNS) affects parents able and willing to monitor proper use of the stimulation device and complete all required rating scales. impaired functioning to a degree that requires immediate initiation of ADHD medication in the opinion of the parents and/or investigator; 2) current diagnosis of pervasive developmental disorder or major depression. history of lifetime psychosis or mania current suicidality history of seizure disorder, tic disorder, or head injury with loss of consciousness.</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>